Ceftriaxone therapy of bone and soft tissue infections in hospital and outpatient settings.
Ceftriaxone, a broad-spectrum cephalosporin with a markedly extended half-life, was administered to 100 patients with 56 bone and 44 soft tissue infections. Sixty-eight received 1 g twice daily, and 32 received 2 g once daily intravenously. Overall, 91% had a satisfactory clinical response, with sim...
Tallennettuna:
| Julkaisussa: | Antimicrob Agents Chemother |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Society for Microbiology (ASM)
1983
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC184802/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6307135/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.23.5.731 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|
